Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells
- 1 July 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 105 (1) , 5-14
- https://doi.org/10.1016/0304-3835(96)04245-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Glutathione deficiency produced by inhibition of its synthesis, and its reversal; Applications in research and therapyPublished by Elsevier ,2002
- Glutathione metabolism and its role in hepatotoxicityPublished by Elsevier ,2002
- A one step PCR procedure for analysis of tumor specific T lymphocyte responsesJournal of Immunological Methods, 1996
- -Glutamyl Transpeptidase Mediation of Tumor Glutathione Utilization In VivoJNCI Journal of the National Cancer Institute, 1996
- Up-regulation of ?-glutamylcysteine synthetase activity in melphalan-resistant human multiple myeloma cells expressing increased glutathione levelsCancer Chemotherapy and Pharmacology, 1994
- Glutathione-related enzymes, glutathione and multidrug resistanceCytotechnology, 1993
- Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthetaseBiochemical and Biophysical Research Communications, 1992
- Phase I study of oxaliplatin in patients with advanced cancerCancer Chemotherapy and Pharmacology, 1990
- Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinumBiomedicine & Pharmacotherapy, 1989
- Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effectsCarcinogenesis: Integrative Cancer Research, 1988